
245PDDuration of response and tumor shrinkage with first-line ribociclib + letrozole in postmenopausal women with HR+, HER2– ABC
Janni, W., Alba Conejo, E., Bachelot, T., Diab, S., Gil-Gil, M., Beck, T.J., Ryvo, L., López, R., Tsai, M., Esteva, F.J., Zamora Aunon, M.P., Kral, Z., Ward, P., Richards, P., Pluard, T.J., Sutradhar,Volume:
28
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx365.008
Date:
September, 2017
Fichier:
PDF, 74 KB
english, 2017